Introduction: Among the main chronic diseases are cardiovascular diseases, with systemic arterial hypertension and diabetes mellitus as important risk factors. The identification of patients with high cardiovascular risk is a priority action in Primary Health Care. The Framingham score is used for this classification. The motivation for this study was the finding of the loss of outpatient follow-up of patients with hypertension and diabetes, which leads to treatment abandonment and a high number of complications. General objective: To implement a monitoring worksheet for hypertensive and diabetic patients in the family health strategy (FHS) and their classification according to Framingham score in low, medium and high risk. Methodology: Hypertensive and diabetic patients were located in the electronic medical record and classified according to the Framingham score using a spreadsheet with VBA computer language in the Microsoft Excel program. Results: A total of 219 medical records were analyzed from September to November 2021. Of the total, 210 users with systemic arterial hypertension (SAH) and 65 with diabetes mellitus (DM). Regarding cardiovascular risk, 86 patients (39.3%) fit into low risk, 37 patients (16.9%) in moderate/intermediate risk and the rest, 96 patients (43.8%) in high cardiovascular risk. Conclusion: The expected results with the organization of users with optimized spreadsheets bring improvements such as better control of four-monthly, six-monthly or annual follow-up according to the classification of cardiovascular risk, active search for absentees through community health agents with guidance on the importance of follow-up in PHC, community health indicators in relation to hypertensive and diabetic patients and targeting intervention proposals aimed at the population at higher risk such as lectures, physical activity groups and conversation circles on the subject. In addition, it is essential to note that there is a high number of consultations for this study group, and monitoring with nursing through its protocols is essential to contribute to improving health care.
No abstract
Introdução: O craniofaringioma (CF) é uma lesão de baixo grau que acomete a região selar e as estruturas neurovasculares adjacentes. Seu diagnóstico diferencial se dá principalmente com os cistos da bolsa de Rathke (CBR), lesões selares raras, normalmente assintomáticas e que se apresentam nos exames de imagem de forma muito semelhante ao CF. Relato de caso: Paciente do sexo masculino, 7 anos, apresentou quadro de déficit dos eixos, corticotrófico, tireotrófico e diabetes insipidus central, associado a hemianopsia bitemporal. A ressonância magnética evidenciou uma lesão expansiva selar cística, sugestiva de CBR. Paciente foi submetido à cirurgia por via endoscópica endonasal e uma biópsia da parede cística confirmou o diagnóstico de CF. Discussão: Os CF são as neoplasias primárias do sistema nervoso central que mais acometem pacientes pediátricos e são classificadas em dois tipos: adamantinomatoso e papilar. As opções terapêuticas são quase sempre cirúrgicas e existem várias vias de acesso que recebem destaque, mas a melhor delas ainda está em discussão. Conclusão: Os CF ainda são um desafio para os neurocirurgiões, devido a sintomatologia discreta. Pelo fato de ser uma lesão rara, é importante que o pediatra e o neurocirurgião estejam atentos para essa possibilidade diagnóstica ao lidar com lesões císticas da região selar.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.